Monoclonal antibodies directed to cd52
AssigneeVet Therapeutics, Inc.
InventorGeneviève Hansen
Life of this patent
Estimating the term…
Abstract
The invention provides antibody to canine or feline or equine antigens, e.g., canine CD52, and methods of making and using antibodies as described.
Claims16
An antibody or antibody fragment thereof recognizing a canine or feline CD52 wherein the antibody reduces the percentage of CD52-expressing cells in a companion animal host.
An antibody or antibody fragment recognizing a canine CD52 or fragment thereof of SEQ ID NO 1 or feline CD52 or fragment thereof of SEQ ID NO 2, said antibody comprising a canine or feline constant region.
An antibody or antibody fragment recognizing canine or feline CD52 and comprising at least one of the CDR regions from an antibody raised against SEQ ID NO 1 or 2, or from the rat anti-human CD52.
Dependencies are inferred from the claim text.